Filing Flows › Koru Medical Systems (KRMD) › Recalls, complaints & regulation
Koru Medical Systems (KRMD): clinical trials
Koru Medical Systems (KRMD) beyond its filings: 1 active clinical trial.
Koru Medical Systems' latest quarter
Koru Medical Systems, Q2 2026: revenue $12.0M (+18% year over year), operating margin 5.2%, net earnings $252K, operating cash flow $216K. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Koru Medical Systems have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.